315 related articles for article (PubMed ID: 37303053)
1. Photodistributed Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and proposal for a new diagnostic classification.
McKinley BJ; Allen ME; Michels N
Eur J Med Res; 2023 Jun; 28(1):188. PubMed ID: 37303053
[TBL] [Abstract][Full Text] [Related]
2. Photodistributed Toxic Epidermal Necrolysis: Case Report and Review of Current Literature.
Gaghan LJ; Coates MM; Crouse LN; Miedema J; Mervak JE; Ziemer CM
JAMA Dermatol; 2022 Jul; 158(7):787-790. PubMed ID: 35507359
[TBL] [Abstract][Full Text] [Related]
3. Comment on: Proposal for a new diagnostic classification of photodistributed Stevens-Johnson syndrome and toxic epidermal necrolysis.
Thwala BN; Teixeira N; Zitha E; Mpungose A; Isaacs T; Peter JG; Lehloenya RJ
Eur J Med Res; 2024 Jan; 29(1):83. PubMed ID: 38287381
[TBL] [Abstract][Full Text] [Related]
4. Systemic lupus erythematosus presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of three cases.
Lee HY; Tey HL; Pang SM; Thirumoorthy T
Lupus; 2011 May; 20(6):647-52. PubMed ID: 21148602
[TBL] [Abstract][Full Text] [Related]
5. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
[TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020.
Wang L; Varghese S; Bassir F; Lo YC; Ortega CA; Shah S; Blumenthal KG; Phillips EJ; Zhou L
Front Med (Lausanne); 2022; 9():949520. PubMed ID: 36091694
[TBL] [Abstract][Full Text] [Related]
7. A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Abulatan IT; Ben-David SG; Morales-Colon LA; Beason E; Fakoya AO
Cureus; 2023 Nov; 15(11):e48728. PubMed ID: 38094551
[TBL] [Abstract][Full Text] [Related]
8. Photodistributed toxic epidermal necrolysis in association with lamotrigine and tanning bed exposure.
Russomanno K; DiLorenzo A; Horeczko J; Deng M; Cardis M; Petronic-Rosic V; Johnson LS; Pasieka HB
JAAD Case Rep; 2021 Aug; 14():68-71. PubMed ID: 34277913
[No Abstract] [Full Text] [Related]
9. The role of prior corticosteroid use on the clinical course of Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies.
Lee HY; Dunant A; Sekula P; Mockenhaupt M; Wolkenstein P; Valeyrie-Allanore L; Naldi L; Halevy S; Roujeau JC
Br J Dermatol; 2012 Sep; 167(3):555-62. PubMed ID: 22639874
[TBL] [Abstract][Full Text] [Related]
10. Role of human leukocyte antigen in anti-epileptic drugs-induced Stevens-Johnson Syndrome/toxic epidermal necrolysis: A meta-analysis.
Rashid M; Rajan AK; Chhabra M; Kashyap A; Chandran VP; Venkataraman R; Nair S; Thunga G
Seizure; 2022 Nov; 102():36-50. PubMed ID: 36183454
[TBL] [Abstract][Full Text] [Related]
11. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
[TBL] [Abstract][Full Text] [Related]
12. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
Gleghorn KL; Voigt C; Kelly B
Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145
[TBL] [Abstract][Full Text] [Related]
13. Analysis of clinical features of oxcarbazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
Yan Q; Liu X; Lei H; Liu R; Hu Y
Front Med (Lausanne); 2023; 10():1232969. PubMed ID: 37881633
[TBL] [Abstract][Full Text] [Related]
14. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis-Like Lupus Erythematosus.
Tankunakorn J; Sawatwarakul S; Vachiramon V; Chanprapaph K
J Clin Rheumatol; 2019 Aug; 25(5):224-231. PubMed ID: 29912772
[TBL] [Abstract][Full Text] [Related]
15. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case-control and cohort studies.
Fukasawa T; Takahashi H; Takahashi K; Tanemura N; Amagai M; Urushihara H
Allergol Int; 2021 Jul; 70(3):335-342. PubMed ID: 33618992
[TBL] [Abstract][Full Text] [Related]
16. Agreement Among Different Scales for Causality Assessment in Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Sivagourounadin K; Rajendran P; Selvarajan S; Ganesapandian M
Curr Drug Saf; 2022; 17(1):40-46. PubMed ID: 34126908
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation-A retrospective chart review.
Weinkle A; Pettit C; Jani A; Keller J; Lu Y; Malachowski S; Trinidad JC; Kaffenberger BH; Ergen EN; Hughey LC; Smith D; Seminario-Vidal L
J Am Acad Dermatol; 2019 Sep; 81(3):749-757. PubMed ID: 31150704
[TBL] [Abstract][Full Text] [Related]
18. Toxic epidermal necrolysis and Stevens-Johnson syndrome after COVID-19 infection and vaccination.
Zou H; Daveluy S
Australas J Dermatol; 2023 Feb; 64(1):e1-e10. PubMed ID: 36484649
[TBL] [Abstract][Full Text] [Related]
19. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
Teraki Y; Shibuya M; Izaki S
Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
[TBL] [Abstract][Full Text] [Related]
20. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa].
Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P
Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
